
CAS Number24526-64-5
Synonyms1,2,3,4-Tetrahydro-2-methyl-4-phenyl-8-isoquinolinamine; 1,2,3,4-tetrahydro-2-methyl-4-phenyl-8-isoquinolinamin; Merital; Nomifensine; R/S-nomifensine; Nomiphensine; Nomifenison; Nomifensine Maleate; (±)-Nomifensine; alival; Nomifensin; linamiphen; 8-Isoquinolinamine,1,2,3,4-tetrahydro-2-methyl-4-phenyl; D,L-nomifensine; 1,2,3,4-tetrahydro-8-amino-2-methyl-4-phenyl-isoquinolin; 8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinoline; 8-amino-4-phenyl-2-methyl-1,2,3,4-tetrahydro-isoquinoline; 8-Amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline; Psicronizer; 2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinolin-8-amine; Hostalival; 2-Methyl-4-phenyl-1,2,3,4-tetrahydro-8-isoquinolinamine
Molecular FormulaC16H18N2
Molecular Weight238.33
Purity96+%
Density1.1±0.1 g/cm3
Boiling Point378.4±42.0 °C at 760 mmHg
Melting Point179-181°
EINECS0
Symbol
Signal WordWarning
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 24526-64-5 |
| Catalog No. | 2A-1123740 |
| Chinese Name | 诺米芬辛 |
| Synonyms | 1,2,3,4-Tetrahydro-2-methyl-4-phenyl-8-isoquinolinamine; 1,2,3,4-tetrahydro-2-methyl-4-phenyl-8-isoquinolinamin; Merital; Nomifensine; R/S-nomifensine; Nomiphensine; Nomifenison; Nomifensine Maleate; (±)-Nomifensine; alival; Nomifensin; linamiphen; 8-Isoquinolinamine,1,2,3,4-tetrahydro-2-methyl-4-phenyl; D,L-nomifensine; 1,2,3,4-tetrahydro-8-amino-2-methyl-4-phenyl-isoquinolin; 8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinoline; 8-amino-4-phenyl-2-methyl-1,2,3,4-tetrahydro-isoquinoline; 8-Amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline; Psicronizer; 2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinolin-8-amine; Hostalival; 2-Methyl-4-phenyl-1,2,3,4-tetrahydro-8-isoquinolinamine |
| Molecular Formula | C16H18N2 |
| Molecular Weight | 238.33 |
| Purity | 96+ |
| Density | 1.1±0.1 g/cm3 |
| Boiling Point | 378.4±42.0 °C at 760 mmHg |
| Melting Point | 179-181° |
| Storage Condition | 2-8℃ |
| Packaging | III |
| Application | Nomifensine is a norepinephrine-dopamine reuptake inhibitor that blocks dopamine and norepinephrine reuptake transporters to increase the amount of norepinephrine and dopamine provided to receptors by |
| EINECS | 0 |
| HTC | 2933499090 |
| UN(IATA) | 0 |
| PubChem ID | 794756 |
| MDL Number | C16H18N2 |
| SMILES | CN1Cc2c(N)cccc2C(c2ccccc2)C1 |
| InChI | InChI=1S/C16H18N2.C4H4O4/c1-18-10-14(12-6-3-2-4-7-12)13-8-5-9-16(17)15(13)11-18;5-3(6)1-2-4(7)8/h2-9,14H,10-11,17H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1- |
| InChI Key | XXPANQJNYNUNES-UHFFFAOYSA-N |
| Hazard Symbols | 6.1(b) |
| Use of | Nomifensine is a norepinephrine-dopamine reuptake inhibitor, increases the amount of synaptic norepinephrine and dopamine available to receptors by blocking the dopamine and norepinephrine reuptake transporters. Properties Biological Activity Chemical & Physical Properties Toxicological Info Safety Info Synthetic Route Precursor & Downstream |
| Tax Rebate | 13.0% |
| Supervision | None. MFN tariff: 6.5%. Ordinary tariff: 20.0% |
| Transport Info | Product name: Summary 2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| 2-METHYL-4-(QUINOLIN-2-YL)BUT-3-YN-2-OL | 831235-64-4 | 2A-0123709 |
| 2-METHYL-4-(QUINOLIN-4-YL)BUT-3-YN-2-OL | 831235-65-5 | 2A-0123710 |
| 2-METHYL-4-(TRIFLUOROMETHOXY)PHENOL | 129676-67-1 | 2A-0123712 |
| 2-METHYL-4-MORPHOLINOANILINE | 581-00-0 | 2A-0123729 |
| 2-METHYL-4-PHENOXYANILINE | 13024-16-3 | 2A-0123739 |
| 2-METHYL-4-PHENYL-2,3-DIHYDRO-1H-INDEN-1-ONE | 153733-74-5 | 2A-0123742 |
| 2-METHYL-4-PHENYLBUT-3-YN-2-OL | 1719-19-3 | 2A-0123743 |
| 2-METHYL-5-(1H-PYRROL-1-YL)ANILINE | 137352-77-3 | 2A-0123759 |
| 2-METHYL-5-(PIPERIDIN-1-YLSULFONYL)ANILINE | 100317-20-2 | 2A-0123768 |
| 2-METHYL-5-(PROPYLSULFONYL)PYRIMIDIN-4-AMINE | 175202-09-2 | 2A-0123773 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA